Clinical Trial Update: MIrabegron With oveRACtive bLadder Symptoms in mEn [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating mirabegron for overactive bladder symptoms in men, sponsored by Seoul National University Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Myrbetriq (mirabegron)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Overactive Bladder | Phase 4 | Status: UNKNOWN